Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep406 | Diabetes (to include epidemiology, pathophysiology) | ECE2017

Episodes of poorly controlled diabetes in 1486 patients admitted in Orthopedic Surgery and Traumatology

Vega Maria Molina , Mora Pilar Losada , Castro Alfonso M Garrido , Almeida Jose M Garcia , Linares Juan L Carrillo , Fuentes Miguel Damas , Garcia Carmen Rodriguez , Perdigones Cristina Diaz

Introduction: Episodes of poorly controlled diabetes (DM) are one of the most frequent medical complications during hospitalization in the elderly population.Objectives: To analyze the prevalence of episodes of diabetic decompensation in patients admitted in Orthopedic Surgery and Traumatology (OST) area.Material and methods: Descriptive analysis of patients admitted to OST Service who presented abnormally high or decreased blood g...

ea0049ep407 | Diabetes (to include epidemiology, pathophysiology) | ECE2017

Episodes of poorly controlled diabetes in 173 patients admitted in Vascular Surgery

Vega Maria Molina , Mora Pilar Losada , Castro Alfonso M Garrido , Almeida Jose M Garcia , Linares Juan L Carrillo , Fuentes Miguel Damas , Garcia Carmen Rodriguez , Perdigones Cristina Diaz

Introduction: Episodes of poorly controlled diabetes (DM) are one of the most frequent medical complications during hospitalization in the elderly population.Objetives: To analyze the prevalence of episodes of diabetic decompensation in patients admitted to the area of Vascular Surgery and Angiology (VS).Material and methods: Descriptive analysis of patients admitted to the VS Service who presented abnormally high or decreased bloo...

ea0049ep614 | Diabetes therapy | ECE2017

New long-acting insulins in type 1 diabetes: implications for real clinical practice

Damas-Fuentes Miguel , Diaz-Perdigones Cristina , Munoz-Garach Araceli , Molina-Vega Maria , Hernandez-Garcia Carmen , Cornejo-Pareja Isabel , Mancha-Doblas Isabel , Tinahones-Madueno Francisco J

The emergence of a new generation of long-acting insulin analogues (insulin degludec -ID- and insulin glargine 300 U/ml -IG300-) has increased treatment options in type 1 diabetes (T1D), demonstrating in clinical trials better metabolic control with lower hypoglycemia rates.Objectives: To assess characteristics of T1D patients who were given ID and IG300 in clinical practice and to evaluate their effect on metabolic control, weight, insulin dose and hypo...

ea0049ep715 | Obesity | ECE2017

Lifestyle of morbidly obese patients awaiting bariatric surgery and in the cohort of patients who have undergone surgery

Mateo-Gavira Isabel , Medina-Rivero Daniel , Rodriguez-Martin Amelia , Novalbos-Ruiz Jose Pedro , Santi-Cano Maria Jose , Diaz-Yelamos A , Aguilar-Diosdado Manuel

Objectives: To determine the habits and lifestyle of the morbidly obese before and after bariatric surgery.Material and methods: Transversal study of two groups of morbidly obese patients attending the Endocrinology Unit of Puerta del Mar, Cádiz: one group before and the other after bariatric surgery. Clinical and analytical data of the patients was collected: socio-demographic and lifestyle characteristics, Bulit-R Questionnaire (Bulimia), BIS (imp...

ea0041oc7.1 | Cardiovascular endocrinology | ECE2016

Lipoprotein lipase DNA methylation: cause or consequence of metabolic disorders

Castellano-Castillo Daniel , Moreno-Indias Isabel , Queipo-Ortuno Maria Isabel , Fernandez-Garcia Jose Carlos , Alcaide-Torres Juan , Tinahones Francisco , Cardona-Diaz Fernando

Introduction: DNA methylation is one of the epigenetic mechanisms existing to regulate gene expression. It is believed that methylation of DNA is susceptible of change by environmental and nutritional factors. Thus, epigenetics provides a mechanism which may explain the etiology of some metabolic disorders and obesity.Aim: The aim of this study is to analyze the DNA methylation level of several lipoprotein lipase (LPL)-promoter-CpG island in human viscer...

ea0041gp124 | Neuroendocrinology | ECE2016

Endothelial damage and thrombotic response in patients with cured Cushing syndrome

Aranda Velazquez Gloria , Mora Porta Mireia , Halperin Irene , Fernandez Rebeca , Diaz-Ricart Maribel , Palomo Marta , Vidal Oscar , Ensenat Joaquim , Casals Gregori , Alexandra Hanzu Felicia

Introduction: Clinical observational studies have reported the persistence of a high cardiovascular risk in patients with cured Cushing’s syndrome (CCS) compared with controls of the same age, gender and BMI. It is still at debated whether this is due to the persistence of comorbidities, hormone deficiencies or chronic changes induced by hypercortisolism. The aim of this translational approach was to investigate the interplay in CCS of the cardiovascular disease in vivo a...

ea0041gp137 | Obesity | ECE2016

Adipose tissue infiltration in normal-weight subjects and its impact on metabolic function

Moreno-Indias Isabel , Oliva-Olivera Wilfredo , Castellano-Castillo Daniel , Lhamyani Said , Fernandez-Garcia Jose Carlos , Queipo-Ortuno Maria Isabel , Cardona-Diaz Fernando , Tinahones Francisco

Objectives: To study for the first time the differences in monocyte/macrophage infiltration, inflammation and adipogenesis in the subcutaneous and visceral adipose tissues of normal-weight subjects who differed in their degree of metabolic syndrome.Methods: The study included 92 normal-weight subjects who differed in their degree of metabolic syndrome. Anthropometric and biochemical parameters were measured. RNA from subcutaneous and visceral adipose tis...

ea0041gp144 | Paediatric Endocrinology & Development | ECE2016

Leptin directly stimulates parathyroid hormone secretion

Lopez Ignacio , Pineda Carmen , Raya Ana I , Rodriguez-Ortiz Maria E , Diaz-Tocados Juan M , Rios Rafel , Rodriguez Mariano , Aguilera-Tejero Escolastico , Almaden Yolanda

A relationship between obesity, plasma leptin concentration and primary hyperparathyroidism has been previously reported. To test the hypothesis that leptin directly stimulates parathyroid hormone (PTH) secretion, in vivo and in vitro experiments were conducted. In the in vivo studies leptin (200 μg/kg, ip) was administered to lean and obese (mutants that do not express active leptin receptor) Zucker rats. The in vitro experiments were ...

ea0041ep210 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2016

Natural history and metabolic implications of the new hormone fibroblast growth factor 21 in uremic patients on peritoneal dialysis

Diez Juan J , Gonzalez Elena , Bajo Maria Auxiliadora , Peso Gloria Del , Grande Cristina , Rodriguez Olaia , Diaz-Almiron Mariana , Iglesiaas Pedro , Selgas Rafael

Background: Human fibroblast growth factor 21 (FGF21) is a new liver hormone that stimulate adipocyte glucose uptake and is involved in regulation of body fat.Objective: To define the natural history of FGF21 in peritoneal dialysis (PD) patients and analyze its relationship with glucose metabolism, peritoneal function, and residual renal function (RRF).Methods: We studied 48 uremic patients undergoing PD. Patients were evaluated at...

ea0041ep597 | Endocrine tumours and neoplasia | ECE2016

Phaeochromocytomas and paragangliomas: A comparative study between sporadic and familial cases in a reference care center in Spain

Luis Guillermo Ropero , Perez Jose Angel Diaz , Gracia Teresa Ruiz , Hernandez Martin Cuesta , Hoyos Emilia Gomez , Hernandez Irene Crespo , Novoa Paz de Miguel

Introduction: Hereditary phaeochromocytoma (PCC) and paraganglioma (PGL) account for 30–35% of cases and have some clinically relevant peculiarities.Material and methods: Retrospective, unicentric cohort study that included all genotyped patients (n=36, 27 with PCC and 9 with PGL) diagnosed at Hospital Clínico San Carlos (Madrid) between 1984 and 2013; 33% were germline mutation carriers (25% pseudohypoxic [PH] phenotype, 75% MAP-kinas...